letter · 2000
Injecting rationale into interferon-β therapy
Three interferon-β (IFNβ) preparations are approved for the treatment of MS: two throughout the world (Betaferon; Schering AG, Berlin, Germany, and Avonex; B...
5 citationsDOI: https://doi.org/10.1212/wnl.54.11.2034